Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension

Respiratory Medicine

Volumn 102, Issue 12, 2008, Pages 1791-1796

  Peled, Nir ^a   Bendayan, Daniele ^a   Shitrit, David ^a   Fox, Ben ^a   Yehoshua, Liora ^a   Kramer, Mordechai R ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Endothelial dysfunction; Pulmonary hypertension; Systemic

Indexed keywords

BOSENTAN; ILOPROST; PROSTACYCLIN; SILDENAFIL; UNIPROST;

ADULT; AGED; ARTERIAL OXYGEN SATURATION; ARTERY OCCLUSION; ARTERY TONE; ARTICLE; BRACHIAL ARTERY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EISENMENGER COMPLEX; ENDOTHELIAL DYSFUNCTION; EXERCISE TEST; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPEREMIA; LUNG ENDOTHELIUM; LUNG FUNCTION TEST; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; PLETHYSMOGRAPH; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; THROMBOEMBOLISM; VASODILATATION; WALKING;

ADULT; AGED; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; EISENMENGER COMPLEX; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; REGIONAL BLOOD FLOW; SCLERODERMA, SYSTEMIC;

EID: 55849152373     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.06.014     Document Type: Article

References (32)

1. Rubin L.J. Primary pulmonary hypertension. N Engl J Med 336 (1997) 111-117
2. McLaughlin V.V., Shillington A., and Rich S. Survival in pulmonary hypertension. The impact of epoprostenol therapy. Circulation 106 (2002) 1447-1482
3. Rubin L.W. Pulmonary hypertension. Proc Am Thorac Soc 3 (2006) 111-115
4. Humbert M., Stibon O., and Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 351 (2004) 1425-1436
5. Runo J.R., and Loyd J.E. Primary pulmonary hypertension. Lancet 361 (2003) 1533-1544
6. Giaid A., and Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333 (1995) 214-221
7. Christman B.W., McPherson C.D., Newman J.H., King G.A., Bernard G.R., Groves B.M., et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327 (1992) 70-75
8. Humbert M., Morrell N., Archer S., Stenmark K.R., MacLean M.R., Lang I.M., et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43 (2004) S13-S24
9. Budhiraja R., Tuder R.M., and Hassoun P.M. Endothelial dysfunction in pulmonary hypertension. Circulation 109 (2004) 159-165
10. Dresdale D.T., Schultz M., and Michtom R.J. Primary pulmonary hypertension. Clinical and hemodynamic study. Am J Med 11 (1951) 686-705
11. Simonneau G., Galiè N., Rubin L.J., Langleben D., Seeger W., Domenighetti G., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 (2004) 5S-12S
12. Bonetti P.O., Pumper G.M., Higano S.T., Holmes D.R., Kuvin J.T., and Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 44 (2004) 2137-2141
13. Kuvin J.T., Patel A.R., Sliney K.A., Pandian N.G., Sheffy J., Schnall R.P., et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 146 (2003) 168-174
14. Bonetti P.O., Barsness G.W., Keelen P.C., Schnell T.I., Pumper G.M., Kuvin J.T., et al. Enhanced external counterpulsation improved endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 41 (2003) 176-178
15. Kuvin J., Patel A., and Karas R. Need for standardization of non-invasive assessment of vascular endothelial function. Am Heart J 1441 (2001) 327-328
16. Kuvin J., Patel A., Sliney K., Pandian N.G., Rand W.M., Udelson J.E., et al. Peripheral vascular endothelial function testing as a non-invasive indicator of coronary artery disease. Am J Coll Cardiol 38 (2001) 1843-1849
17. Schroeter H., Heiss C., Balzer J., Kleibongard P., Keen C.L., Hollenberg N.K., et al. Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103 4 (2006) 1024-1029
18. Meredith I.T., Currie K.E., Anderson T.J., Roddy M.A., Ganz P., and Vreager M.A. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 270 (1996) H1435-H1440
19. Yinon D., Lowenstein L., Suraya S., Beloosesky R., Zmora O., Malhotra A., et al. Pre-eclampsia is associated with sleep-disordered breathing and endothelial dysfunction. Eur Respir J 27 (2006) 328-333
20. Itzhaki S., Lave L., Pillar G., Tal G., and Lavie P. Endothelial dysfunction in obstructive sleep apnea measured by peripheral arterial tone response in the finger to reactive hyperemia. Sleep 28 5 (2005) 594-600
21. Hughes R., Tong J., Oats C., Lordan J., and Corris P.A. Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary hypertension. Chest 128 (2005) 617S
22. Wolff B., Lodziewski S., Bollmann T., Opitz C.F., and Ewert R. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. Am Heart J 153 (2007) 1088-10e1-e8
23. Bull T.M., Golpon H., Hebbel R.P., Solovey A., Cool C.D., Tuder R.M., et al. Circulating endothelial cells in pulmonary hypertension. Thromb Haemost 90 4 (2003) 698-703
24. Dorfmuller P., Perros F., Balabanian K., and Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 22 (2003) 358-363
25. Eddahibi S., Humbert M., Fadel E., Raffestin B., Darmon M., Capron F., et al. Serotonin transporter overexpression is responsible for pulmonary arterial smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 108 (2001) 1141-1150
26. Friedman R., Mears J.G., and Barst R.J. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension. Circulation 96 (1997) 2782-2784
27. Velez-Roa S., Ciarka A., Najem B., Vachiery J.L., Naeije R., and Van de Borne P. Increased sympathetic nerve activity in pulmonary hypertension. Circulation 110 (2004) 1308-1312
28. Xu W., Kaneko F.T., Zheng S., Comhair S.A., Janocha A.J., Goggans T., et al. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 18 14 (2004 Nov) 1746-1748
29. Pietra G.G., Edwards W.D., Kay J.M., Rich S., Kernis J., Schloo B., et al. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation 80 (1989) 1198-1206
30. Galiè N., Torbicki A., Barst R., Dartevelle P., Haworth S., Higenbottam T., et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. Eur Heart J 25 (2004) 2243-2278
31. Nakamura M., Yoshida H., Naganuma Y., Kon H., Sugawara S., and Hiramori K. Peripheral vasodilatory dysfunction in adult patients with congenital heart disease and severely elevated pulmonary vascular resistance. Angiology 53 6 (2002) 715-720
32. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265